96. クローン病 Crohn disease Clinical trials / Disease details

臨床試験数 : 2,400 / 薬物数 : 1,391 - (DrugBank : 267) / 標的遺伝子数 : 170 - 標的パスウェイ数 : 215

22 trials found

diseases per page:

Showing 1 to 10 of 22 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05242471 (ClinicalTrials.gov)	May 20, 2022	15/2/2022	A Study of Combination Therapy With Guselkumaband Golimumab in Participants With Moderately to Sever ...	A Phase 2b Randomized, Double-blind, Active-controlled, Parallel-group, Multicenter Study to Evaluat ...	Crohn's Disease	Biological: Guselkumab;Biological: Golimumab;Biological: JNJ-78934804	Janssen Research & Development, LLC	NULL	Not yet recruiting	18 Years	65 Years	All	650	Phase 2	Italy
2	NCT05197049 (ClinicalTrials.gov)	January 17, 2022	17/1/2022	A Study of GuselkumabSubcutaneous Therapy in Participants With Moderately to Severely Active Crohn's ...	A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Ef ...	Crohn Disease	Drug: Guselkumab Dose 1;Drug: Guselkumab Dose 2;Drug: Guselkumab Dose 3;Drug: Placebo	Janssen Research & Development, LLC	NULL	Recruiting	18 Years	N/A	All	318	Phase 3	United States;Australia;Belarus;Belgium;Bosnia and Herzegovina;Brazil;China;Croatia;Czechia;France;G ...
3	JPRN-JapicCTI-205298	10/6/2020	26/05/2020	A Study of Guselkumab in Participants with Moderately to Severely Active Crohn's Disease	A Phase 3, Open-label, Multicenter Study to Evaluate the Safety and Efficacy of Guselkumabin Partici ...	Crohn's Disease	Intervention name : Guselkumab INN of the intervention : Guselkumab Dosage And administration of the i ...	Janssen Pharmaceutical K.K.	NULL	recruiting	18		BOTH	25	Phase 3	Japan
4	NCT04397263 (ClinicalTrials.gov)	June 10, 2020	18/5/2020	A Study of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease	A Phase 3, Open-label, Multicenter Study to Evaluate the Safety and Efficacy of Guselkumabin Partici ...	Crohns Disease	Drug: Guselkumab	Janssen Pharmaceutical K.K.	NULL	Recruiting	18 Years	N/A	All	25	Phase 3	Japan
5	EUCTR2017-002195-13-GB (EUCTR)	05/06/2019	28/02/2018	A Study of the Efficacy and Safety of Guselkumabin Participants with Moderately to Severely Active C ...	A Phase 2/3, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter P ...	Moderately to Severely Active Crohn's Disease MedDRA version: 20.0;Level: PT;Classification code 100 ...	Product Name: guselkumab Product Code: CNTO1959 INN or Proposed INN: GUSELKUMAB Product Name: guselkuma ...	Janssen-Cilag International NV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	2000	Phase 2;Phase 3	Portugal;Belarus;Serbia;United States;Saudi Arabia;Taiwan;Slovakia;Greece;Spain;Ukraine;Lebanon;Isra ...
6	EUCTR2017-002195-13-PT (EUCTR)	18/03/2019	23/07/2018	A Study of the Efficacy and Safety of Guselkumabin Participants with Moderately to Severely Active C ...	A Phase 2/3, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter P ...	Moderately to Severely Active Crohn's Disease MedDRA version: 20.0;Level: PT;Classification code 100 ...	Product Name: guselkumab Product Code: CNTO1959 INN or Proposed INN: GUSELKUMAB Product Name: guselkuma ...	Janssen-Cilag International NV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	2000	Phase 2;Phase 3	Serbia;United States;Portugal;Belarus;Saudi Arabia;Taiwan;Slovakia;Greece;Spain;Ukraine;Lebanon;Russ ...
7	EUCTR2017-002195-13-IT (EUCTR)	05/11/2018	22/01/2021	A Study of the Efficacy and Safety of Guselkumabin Participants with Moderately to Severely Active C ...	A Phase 2/3, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter P ...	Moderately to Severely Active Crohn's Disease MedDRA version: 20.0;Level: PT;Classification code 100 ...	Product Name: guselkumab Product Code: [CNTO1959] INN or Proposed INN: GUSELKUMAB Product Name: guselku ...	JANSSEN CILAG INTERNATIONAL NV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	2000	Phase 2;Phase 3	Portugal;Belarus;Serbia;United States;Saudi Arabia;Taiwan;Slovakia;Greece;Spain;Ukraine;Lebanon;Isra ...
8	JPRN-JapicCTI-183950	20/9/2018	07/05/2018	A Study of the Efficacy and Safety of Guselkumabin Participants with Moderately to Severely Active C ...	A Phase 2/3, Randomized, Double-blind, Placebo- and Active-controlled, Parallelgroup, Multicenter Pr ...	Crohn's Disease	Intervention name : Guselkumab INN of the intervention : Guselkumab Dosage And administration of the i ...	Janssen Pharmaceutical K.K.	NULL	recruiting	18		BOTH	2000	Phase 2-3	Japan, North America
9	EUCTR2017-002195-13-NL (EUCTR)	10/09/2018	30/04/2018	A Study of the Efficacy and Safety of Guselkumabin Participants with Moderately to Severely Active C ...	A Phase 2/3, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter P ...	Moderately to Severely Active Crohn's Disease MedDRA version: 20.0;Level: PT;Classification code 100 ...	Product Name: guselkumab Product Code: CNTO1959 INN or Proposed INN: GUSELKUMAB Product Name: guselkuma ...	Janssen-Cilag International NV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	2000	Phase 2;Phase 3	Portugal;Belarus;Serbia;United States;Saudi Arabia;Taiwan;Slovakia;Greece;Spain;Ukraine;Lebanon;Isra ...
10	EUCTR2017-002195-13-HR (EUCTR)	07/09/2018	16/05/2019	A Study of the Efficacy and Safety of Guselkumabin Participants with Moderately to Severely Active C ...	A Phase 2/3, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter P ...	Moderately to Severely Active Crohn's Disease MedDRA version: 20.0;Level: PT;Classification code 100 ...	Product Name: guselkumab Product Code: CNTO1959 INN or Proposed INN: GUSELKUMAB Product Name: guselkuma ...	Janssen-Cilag International NV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	2000	Phase 2;Phase 3	Portugal;Belarus;Serbia;United States;Saudi Arabia;Taiwan;Slovakia;Greece;Spain;Ukraine;Lebanon;Isra ...

First Previous1 2 3Next Last